Idarubicin 1mg/ml injection 5 & 10 ml - recall
Read the official alert on GOV.UK — MedRegWatch re-presents it; GOV.UK is the authoritative source.
| Type | Medicines recall/notification |
|---|---|
| Issued | 13 Aug 2014 |
| Reference | EL (14)A/13 |
| Product licences | PL 00289/1080 |
13 August 2014
Class 2 medicines recall
Action within 48 hours
Hospital ward, hospital pharmacy, clinic and wholesale-level recall
MDR 09-08/14
Product details
Teva UK Limited
Idarubicin 1mg/ml injection 5 & 10 ml
(Idarubicin)
PL 00289/1080
Alert details
- Batch number: 3320413
- Expiry date: Apr-16
- Pack size: 5 ml
- First distributed: 12-Jul-2013
- Batch number: 3330413
- Expiry date: Apr-16
- Pack size: 10 ml
- First distributed: 12-Jul-2013
Teva UK Limited is recalling, as a precautionary measure, 2 batches of Idarubicin 1mg/ml injection following discovery of a red precipitate during stability testing under cold storage conditions. Adverse effects in patients are not expected due to this issue, but cannot be excluded. No complaints or adverse reaction reports on the batches mentioned above which may be related to this issue have been received by the company to date.
Remaining stock of these batches should be quarantined and returned to the original supplier for credit. For stock enquiries please contact Teva UK Limited Customer Service on 0800 590 502.
For medical information enquiries please contact Teva UK Limited by phone on 0207 5407117 or by email to medinfo@tevauk.com
Recipients of this drug alert should bring it to the attention of relevant contacts by copy of this letter.